Literature DB >> 8429852

Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy.

M Simons1, G Leclerc, R D Safian, J M Isner, L Weir, D S Baim.   

Abstract

BACKGROUND: Neointimal proliferation leading to restenosis frequently develops after coronary angioplasty. This process is associated with a change in vascular smooth-muscle cells from a contractile (quiescent) phenotype to a synthetic or proliferating (activated) one. We investigated whether the presence of activated smooth-muscle cells in coronary lesions at the time of coronary atherectomy predisposes patients to subsequent restenosis.
METHODS: We used in situ hybridization to study the expression of messenger RNA in coronary-atherectomy specimens from 20 patients. Plaque material was hybridized with a probe for the B isoform of human nonmuscle myosin heavy chain, a major nonmuscle myosin isoform in activated, but not quiescent, smooth-muscle cells. Angiographic follow-up data were obtained a mean (+/- SD) of 174 +/- 54 days after atherectomy in 16 of the 20 patients, and the extent of recurrent luminal narrowing was analyzed quantitatively. The presence of restenosis was assessed by exercise thallium scintigraphy in the other four patients.
RESULTS: Atherectomy specimens from 10 of the 20 patients showed hybridization with the probe, defined as the clustering of more than 20 silver grains per cell nucleus in more than 10 nuclei in five high-power fields (x250); specimens from the other 10 patients showed no such hybridization. At follow-up, restenosis had developed in 8 of the 10 patients with positive hybridization results, but was absent in 9 of the 10 patients with negative results (P = 0.007). The degree of late loss in luminal diameter was significantly higher in patients with positive hybridization results than in those with negative results (ratio of late loss to immediate gain after atherectomy, 0.76 +/- 0.3 vs. 0.36 +/- 0.3; P < 0.001).
CONCLUSIONS: We conclude that the expression of the B isoform of nonmuscle myosin heavy chain is increased in some coronary atherosclerotic plaques and that this increase in expression identifies a group of lesions at high risk for restenosis after atherectomy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429852     DOI: 10.1056/NEJM199303043280903

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  15 in total

1.  Characterization of the nonmuscle myosin heavy chain IIB promoter: regulation by E2F.

Authors:  L Weir; D Chen
Journal:  Gene Expr       Date:  1996

2.  Differential response of rat aortic and coronary smooth muscle cell DNA synthesis in response to mechanical stretch in vitro.

Authors:  M S Lundberg; K S Ramos; W M Chilian
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-01       Impact factor: 2.416

3.  Antiproliferative and c-myc mRNA suppressive effect of tranilast on newborn human vascular smooth muscle cells in culture.

Authors:  K Miyazawa; S Hamano; A Ujiie
Journal:  Br J Pharmacol       Date:  1996-06       Impact factor: 8.739

4.  Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells.

Authors:  M C Weiser; N A Grieshaber; P E Schwartz; R A Majack
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

5.  Cloning of the cDNA encoding human nonmuscle myosin heavy chain-B and analysis of human tissues with isoform-specific antibodies.

Authors:  C L Phillips; K Yamakawa; R S Adelstein
Journal:  J Muscle Res Cell Motil       Date:  1995-08       Impact factor: 2.698

6.  Re: Histological analysis of atherectomy specimens: an opportunity neglected to guide therapy preventing restenosis.

Authors:  X Yang; H Manninen; S Soimakallio
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Mar-Apr       Impact factor: 2.740

7.  Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.

Authors:  Randolph Hutter; Li Huang; Walter S Speidl; Chiara Giannarelli; Paul Trubin; Gerhard Bauriedel; Mary E Klotman; Valentin Fuster; Juan J Badimon; Paul E Klotman
Journal:  Circulation       Date:  2013-09-16       Impact factor: 29.690

8.  Characterization of cloned aortic smooth muscle cells from young rats.

Authors:  J M Lemire; C W Covin; S White; C M Giachelli; S M Schwartz
Journal:  Am J Pathol       Date:  1994-05       Impact factor: 4.307

9.  RNA interference targeting embryonic myosin heavy chain isoform inhibited mRNA expressions of phenotype markers in rabbit cultured vascular smooth muscle cells.

Authors:  Seiji Shimada; Masanori Sunagawa; Kazuhiko Hanashiro; Mariko Nakamura; Tadayoshi Kosugi
Journal:  Heart Vessels       Date:  2007-01-26       Impact factor: 2.037

10.  Tyrosine phosphorylation of platelet derived growth factor beta receptors in coronary artery lesions: implications for vascular remodelling after directional coronary atherectomy and unstable angina pectoris.

Authors:  J Abe; J Deguchi; Y Takuwa; K Hara; Y Ikari; T Tamura; M Ohno; K Kurokawa
Journal:  Heart       Date:  1998-04       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.